You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Lipid disorders

Metreleptin for treating lipodystrophy

  • Highly specialised technologies guidance
  • Reference number: HST14
  • Published:  24 February 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The condition
  • 3 The technology
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Evaluation committee members and NICE project team
  • Update information

Update information

June 2021: We added HbA1c levels in mmol/mol to sections 1.2, 4.14, 4.35 and 4.37 of the guidance, to reflect the units used in clinical practice.

ISBN: 978-1-4731-3472-0


Previous page 6 Evaluation committee members and NICE project team
Back to top